Design, synthesis and α-glucosidase inhibition study of novel embelin derivatives

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5–S10.
   PubMedGoogle Scholar
• Kharroubi AT, Darwish HM. Diabetes mellitus: the epidemic of the century. World J Diabetes 2015;6:850–67.
   PubMed Web of Science ®Google Scholar
• WHO. The top 10 causes of death. Available from: https://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death [last accessed 6 Sep 2019].
   Google Scholar
• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 2012;8:228–36.
   Web of Science ®Google Scholar
• Zaccardi F, Webb DR, Yates T, et al. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J 2016;92:63–9.
   PubMed Web of Science ®Google Scholar
• Wu PP, Zhang BJ, Cui XP, et al. Synthesis and biological evaluation of novel ursolic acid analogues as potential alpha-glucosidase inhibitors. Sci Rep 2017;7:45578.
   PubMed Web of Science ®Google Scholar
• Nyenwe EA, Jerkins TW, Umpierrez GE, et al. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 2011;60:1–23.
   PubMed Web of Science ®Google Scholar
• Kumar S, Narwal S, Kumar V, et al. Alpha-glucosidase inhibitors from plants: a natural approach to treat diabetes. Pharmacogn Rev 2011;5:19–29.
   PubMedGoogle Scholar
• Santos CMM, Freitas M, Fernandes E. A comprehensive review on xanthone derivatives as α-glucosidase inhibitors. Eur J Med Chem 2018;157:1460–79.
   PubMed Web of Science ®Google Scholar
• Esmaeili S, Azizian S, Shahmoradi B, et al. Dipyridamole inhibits α-amylase/α-glucosidase at sub-micromolar concentrations: in-vitro, in-vivo and theoretical studies. Bioorg Chem 2019;88:102972.
   PubMed Web of Science ®Google Scholar
• Zhong YY, Chen HS, Wu PP, et al. Synthesis and biological evaluation of novel oleanolic acid analogues as potential α-glucosidase inhibitors. Eur J Med Chem 2019;164:706–16.
   PubMed Web of Science ®Google Scholar
• Van de Laar FA, Lucassen PL, Akkermans RP, et al. α-Glucosidase inhibitors for patients with type 2 diabetes. Diabetes Care 2005;28:154–63.
   PubMed Web of Science ®Google Scholar
• Joshi SR, Standl E, Tong N, et al. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert Opin Pharmacother 2015;16:1959–81.
   PubMed Web of Science ®Google Scholar
• Bonora E. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight. Int J Clin Pract Suppl 2007;61:19–28.
   Google Scholar
• Poojari R. Embelin – a drug of antiquity: shifting the paradigm towards modern medicine. Expert Opin Investig Drugs 2014;23:427–44.
   PubMed Web of Science ®Google Scholar
• Sheng Z, Ge S, Gao M, et al. Synthesis and biological activity of embelin and its derivatives: an overview. Mini Rev Med Chem 2019. E-pub ahead of print. doi:10.2174/1389557519666191015202723
   PubMed Web of Science ®Google Scholar
• Prabhu KS, Achkar IW, Kuttikrishnan S, et al. Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancer. Future Med Chem 2018;10:961–76.
   PubMed Web of Science ®Google Scholar
• Ko JH, Lee SG, Yang W, et al. The application of embelin for cancer prevention and therapy. Molecules 2018;23:621.
   Web of Science ®Google Scholar
• Chitra M, Shyamala Devi CS, Sukumar E. Antibacterial activity of embelin. Fitoterapia 2003;74:401–3.
   PubMed Web of Science ®Google Scholar
• Feresin GE, Tapia A, Sortino M, et al. Bioactive alkyl phenols and embelin from Oxalis erythrorhiza. J Ethnopharmacol 2003;88:241–7.
   PubMed Web of Science ®Google Scholar
• Joshi R, Kamat JP, Mukherjee T. Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies. Chem-Biol Interact 2007;167:125–34.
   PubMed Web of Science ®Google Scholar
• Mahendran S, Badami S, Ravi S, et al. Synthesis and evaluation of analgesic and anti-inflammatory activities of most active free radical scavenging derivatives of embelin – a structure-activity relationship. Chem Pharm Bull 2011;59:913–9.
   PubMed Web of Science ®Google Scholar
• Afzal M, Gupta G, Kazmi I, et al. Evaluation of anxiolytic activity of embelin isolated from Embelia ribes. Biomed Aging Pathol 2012;2:45–7.
   Google Scholar
• Singh IP, Bharate SB, Singh A, et al. Fate of embelin in Pippalyadi Yoga, an ayurvedic oral contraceptive: structure of embelin-borax complex and evaluation of anti-fertility activity. Indian J Chem 2007;46B:320–5.
   Google Scholar
• Radhakrishnan N, Gnanamani A. 2,5-dihydroxy-3-undecyl-1,4-benzoquinone (embelin) – a second solid gold of India – a review. Int J Pharm Pharmacol Sci 2014;6:23–30.
   Google Scholar
• Naik SR, Niture NT, Ansari AA, et al. Anti-diabetic activity of embelin: involvement of cellular inflammatory mediators, oxidative stress and other biomarkers. Phytomedicine 2013;20:797–804.
   PubMed Web of Science ®Google Scholar
• Mahendran S, Badami S, Maithili V. Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats. Biomed Prev Nutr 2011;1:25–31.
   Google Scholar
• Alam MS, Ahad A, Abidin L, et al. Embelin-loaded oral niosomes ameliorate streptozotocin-induced diabetes in Wistar rats. Biomed Pharmacother 2018;97:1514–20.
   PubMed Web of Science ®Google Scholar
• Durg S, Veerapur VP, Neelima S, et al. Antidiabetic activity of Embelia ribes, embelin and its derivatives: a systematic review and meta-analysis. Biomed Pharmacother 2017;86:195–204.
   PubMed Web of Science ®Google Scholar
• Dang PH, Nguyen HX, Nguyen NT, et al. α-Glucosidase inhibitors from the stems of Embelia ribes. Phytother Res 2014;28:1632–6.
   PubMed Web of Science ®Google Scholar
• Dang PH, Nguyen NT, Nguyen HX, et al. α-Glucosidase inhibitors from the leaves of Embelia ribes. Fitoterapia 2015;100:201–7.
   PubMed Web of Science ®Google Scholar
• Filosa R, Peduto A, Schaible AM, et al. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes. Eur J Med Chem 2015;94:132–9.
   PubMed Web of Science ®Google Scholar
• Wu PP, Zhang K, Lu YJ, et al. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives. Eur J Med Chem 2014;80:502–8.
   PubMed Web of Science ®Google Scholar
• Sheng Z, Ge S, Xu X, et al. Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors. MedChemComm 2018;9:897.
   PubMed Web of Science ®Google Scholar